These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oseltamivir resistance in influenza A (H5N1) infection. Gupta RK; Nguyen-Van-Tam JS N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890 [No Abstract] [Full Text] [Related]
3. Neuraminidase inhibitors for influenza. Moscona A N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
4. Review says oseltamivir and zanamivir should be kept for epidemics of flu. Mayor S BMJ; 2006 Jan; 332(7535):196. PubMed ID: 16439387 [No Abstract] [Full Text] [Related]
5. Neuraminidase inhibitors for treatment of influenza. Ebell MH Am Fam Physician; 2004 Jun; 69(12):2824. PubMed ID: 15222647 [No Abstract] [Full Text] [Related]
6. [Neuraminidase inhibitor permitted. The first pill against influenza]. MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367 [No Abstract] [Full Text] [Related]
8. Two neuraminidase inhibitors for treatment of influenza. Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051 [No Abstract] [Full Text] [Related]
9. [New diagnostic possibilities and medications. Fit for influenza?]. Wutzler P MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540 [No Abstract] [Full Text] [Related]
11. [What do your patients want to know now? The most frequent questions about avian influenza]. MMW Fortschr Med; 2006 Mar; 148(9):13. PubMed ID: 16566386 [No Abstract] [Full Text] [Related]
12. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Wei DQ; Du QS; Sun H; Chou KC Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045 [TBL] [Abstract][Full Text] [Related]
14. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice. Vogel GE Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352 [TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses. Hayden F; Klimov A; Tashiro M; Hay A; Monto A; McKimm-Breschkin J; Macken C; Hampson A; Webster RG; Amyard M; Zambon M Antivir Ther; 2005; 10(8):873-7. PubMed ID: 16430192 [TBL] [Abstract][Full Text] [Related]
16. [Oral neuraminidase inhibitor and an early warning system. New weapons against influenza]. Lange W; Vogel GE MMW Fortschr Med; 2003 Jan; 145(3-4):36-7. PubMed ID: 12619232 [No Abstract] [Full Text] [Related]
17. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
18. Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors. Sato M; Hosoya M; Kato K; Suzuki H Pediatr Infect Dis J; 2005 Oct; 24(10):931-2. PubMed ID: 16220098 [TBL] [Abstract][Full Text] [Related]
19. [New flu therapy. Progress or burden for the budget?]. Vogel GE MMW Fortschr Med; 2000 Feb; 142(8):14. PubMed ID: 10810861 [No Abstract] [Full Text] [Related]